Tag: Gilead Sciences Inc

Drugmakers race to find a place in the next wave of obesity drugs

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

Trump tariff fallout: Some industries grapple with lingering effects one year later

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

FDA vaccine head will step down in April after string of controversial decisions

Novartis, Genentech file suit alleging illegal importation of prescription drug

FDA chief Marty Makary says ‘everything should be over-the-counter’ unless drug is unsafe or addictive